Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.
about
Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factorsBurkitt's lymphoma in Africa, a review of the epidemiology and etiologyZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virusGenetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, ZtaBZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTAProtein kinase C-independent activation of the Epstein-Barr virus lytic cycle.Epstein Barr virus and Helicobacter pylori co-infection are positively associated with severe gastritis in pediatric patients.Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latencyPhosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.Activation of the Epstein-Barr virus lytic cycle by the latex of the plant Euphorbia tirucalli.Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs dPhosphorylation events during viral infections provide potential therapeutic targets.The Epstein-Barr virus immediate-early protein BZLF1 induces expression of E2F-1 and other proteins involved in cell cycle progression in primary keratinocytes and gastric carcinoma cells.Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells.Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivatorTranscriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells.Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivationInteraction with the Epstein-Barr virus helicase targets Zta to DNA replication compartments.Disruption of Epstein-Barr virus latency in the absence of phosphorylation of ZEBRA by protein kinase C.The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation.Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1.A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication.Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter.The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis.
P2860
Q22253362-C0E7A67D-92D2-4B11-ACEF-7F424AB27E54Q27485581-1C457D81-6551-48D7-865F-8DAA5EE92737Q28471803-D9871ED5-14B4-45EF-8E5A-573552014737Q33822549-78E1DDD5-1F3F-4D9E-A519-E6E7BE408F3EQ33843046-BF88458C-6F07-4F1F-8F84-AD2A53A75DD2Q33874843-EC79AAF3-1999-4261-969F-381CA6BA4010Q34092690-4B1BC59E-A724-486F-8BFA-11AB7BD37E4BQ34363413-401E646E-F489-460C-A1AA-2D9165C8EE89Q34702051-C870FF0D-D9B2-4708-A962-960776F3BFABQ35024349-8064FD6F-51F4-46BC-A267-EF4D6625FF86Q35076733-AED67622-5CDA-46E5-A08E-B3BC9E72AEB3Q35122852-72C1A6A7-2248-4748-BAA5-16DA61DA1FC6Q36648870-BAC0E8D2-C5A9-4D02-93A4-AC5043CB4E30Q37093134-B39FA25B-94A1-4760-829F-05CB88662DE6Q37422745-7AB01945-3858-4539-82FC-1CFA97E8C159Q37960427-A7A60D33-8516-4484-84C8-6AC9049D1C57Q38360833-C78CFAF3-65DD-47B9-A652-5B08DE6CD2A7Q38943928-4CE1CC59-A6F2-4050-A628-CCE14BB387A9Q39593916-F09B3C64-8DA8-4982-8D3F-C1DF53E79A7FQ39596534-B5F76242-56CC-463B-840E-93C40E5A7EA7Q39604695-1BB21ADE-DB29-4E8B-9859-B111A7DC3B4EQ39607106-96A0BDD2-5DD4-4877-836E-B16940035E40Q39685869-51172E57-B827-4231-A754-F36C98B53EB7Q39743627-F502088E-F66F-4456-BE47-14998764B1E3Q40280193-135BBD11-6480-47C3-8EBF-1C40A2BBFAFBQ40361661-23289FF8-F959-462F-9901-239D2E16B1E0Q40530797-31992AAF-535E-4A10-A1B3-ADE5F774A222Q54245037-7F3487A0-3D8C-40D0-B929-905FC302B844
P2860
Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Activation of the Epstein-Barr ...... etate-induced phosphorylation.
@ast
Activation of the Epstein-Barr ...... etate-induced phosphorylation.
@en
type
label
Activation of the Epstein-Barr ...... etate-induced phosphorylation.
@ast
Activation of the Epstein-Barr ...... etate-induced phosphorylation.
@en
prefLabel
Activation of the Epstein-Barr ...... etate-induced phosphorylation.
@ast
Activation of the Epstein-Barr ...... etate-induced phosphorylation.
@en
P2093
P2860
P1433
P1476
Activation of the Epstein-Barr ...... cetate-induced phosphorylation
@en
P2093
S Dammeier
W Hammerschmidt
P2860
P304
P577
1998-10-01T00:00:00Z